This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback